Rehmann Capital Advisory Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Rehmann Capital Advisory Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,000	Closed	-$249K	–	411
2016 Q4	$249K	Hold	20,000	–	–	0.05%	312
2016 Q3	$274K	Hold	20,000	–	–	0.05%	274
2016 Q2	$148K	Hold	20,000	–	–	0.03%	354
2016 Q1	$128K	Buy	+20,000	New	+$112K	0.02%	352

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Rehmann Capital Advisory Group's ARIA Position: Q1 2017 in Review

Rehmann Capital Advisory Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 20,000 shares — an estimated $249K sold.

Rehmann Capital Advisory Group first reported a position in ARIA in Q1 2016 and held it in 4 quarters. The position peaked at $274K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Rehmann Capital Advisory Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Rehmann Capital Advisory Group sold 20,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $249K.
Rehmann Capital Advisory Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2016 and held it in 4 quarters.
Rehmann Capital Advisory Group's Ariad Pharmaceuticals Inc position peaked at $274K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2017, filed 24 Apr 2017.